An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas

Neurosurgical Focus
Sam Q SunAlbert H Kim

Abstract

The management of WHO Grade II "atypical" meningiomas (AMs) and Grade III "malignant" meningiomas (MMs) remains controversial and under-investigated in prospective studies. The roles of surgery, radiation therapy, radiosurgery, and chemotherapy have been incompletely delineated. This has left physicians to decipher how they should treat patients on a case-by-case basis. In this study, the authors review the English-language literature on the management and clinical outcomes associated with AMs and MMs diagnosed using the WHO 2000/2007 grading criteria. Twenty-two studies for AMs and 7 studies for MMs were examined in detail. The authors examined clinical decision points using the literature and concepts from evidence-based medicine. Acknowledging the retrospective nature of the studies concerning AM and MM, the authors did find evidence for the following clinical strategies: 1) maximal safe resection of AM and MM; 2) active surveillance after gross-total resection of AM; 3) adjuvant radiation therapy after subtotal resection of AM, especially in the absence of putative radioresistant features; and 4) adjuvant radiation therapy after resection of MM.

References

Jul 1, 1993·Brain Pathology·P KleihuesB W Scheithauer
Mar 1, 1996·International Journal of Radiation Oncology, Biology, Physics·M F MilosevicW J Simpson
Jun 26, 2003·Neurosurgery·Makoto NakamuraMadjid Samii
Sep 25, 2003·Surgical Neurology·Anthony E HarrisL Dade Lunsford
Mar 18, 2005·Neuropathology and Applied Neurobiology·J WillisD Everington
Sep 8, 2005·Neurosurgery·Ashok Modha, Philip H Gutin
Oct 19, 2006·Journal of Neurosurgery·Shigetoshi YanoUNKNOWN Kumamoto Brain Tumor Research Group
Mar 16, 2007·Journal of Neuro-oncology·Hideyuki KanoNobuo Hashimoto
May 15, 2007·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Jordi BrunaAvelina Tortosa
Jun 5, 2007·Journal of Neurosurgery·Carlos A MattozoMichael T Selch
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Sep 4, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·S-Y YangH-W Jung
Nov 6, 2007·Journal of Neurosurgery·Marc SindouThomas Lieutaud
Dec 12, 2007·British Journal of Neurosurgery·S J SmithD C Macarthur
Feb 11, 2009·International Journal of Radiation Oncology, Biology, Physics·Christos BoskosJean-Jacques Mazeron
May 12, 2009·International Journal of Radiation Oncology, Biology, Physics·Lewis A RosenbergJohn H Suh
Jun 30, 2009·Journal of Neuro-oncology·Andrew D NordenPatrick Y Wen
Jun 30, 2009·Journal of Neuro-oncology·Anne DurandJacques Guyotat
Mar 17, 2010·Journal of Neurosurgery·Michael E SughrueMichael W McDermott
May 11, 2010·Journal of Neurosurgery·Michael E SughrueAndrew T Parsa
Aug 27, 2010·Journal of Neuro-oncology·Leland RogersMichael A Vogelbaum
Aug 31, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Kyungil JoJong Hyun Kim
Sep 3, 2010·Journal of Neuro-oncology·Christian Mawrin, Arie Perry
Jun 28, 2011·Journal of Neurosurgery·Richard MairThomas A Carroll
Sep 23, 2011·Journal of Neuro-oncology·David A ReardonHenry S Friedman
Dec 1, 2011·Journal of Neuro-oncology·Marc C Chamberlain
Dec 3, 2011·Neurosurgical Focus·Roukoz ChamounWilliam T Couldwell
Feb 24, 2012·Journal of Neuro-oncology·Albert AttiaEdward G Shaw
Mar 7, 2012·Cancer·Matthias PreusserWalter Berger
Mar 13, 2012·Neuro-oncology·Hanna van AlkemadeLukas J A Stalpers
May 1, 2012·Journal of Neuro-oncology·Lakshmi NayakThomas J Kaley
Jun 21, 2012·Technology in Cancer Research & Treatment·A W ChanJ S Loeffler

❮ Previous
Next ❯

Citations

Mar 26, 2016·Neurosurgery Clinics of North America·Simon ButtrickMichael E Ivan
Mar 26, 2016·Neurosurgery Clinics of North America·Michael KarsyRandy L Jensen
Dec 22, 2015·Neurocirugía·Luis Real-PeñaJosé Manuel González-Darder
Apr 25, 2016·World Neurosurgery·Michael ZhangSteven D Chang
Jun 25, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Iddo PaldorYigal Shoshan
Jul 3, 2016·Neuro-Chirurgie·M MessererR T Daniel
Sep 10, 2016·Journal of Neurosurgery·Hilary P BagshawDennis C Shrieve
Nov 4, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yongli JiClaire Verschraegen
Feb 13, 2016·Journal of Biophotonics·Marc ZanelloDarine Abi-Haidar
Jul 22, 2017·Journal of Neurosurgery·Andrew OrtonGita Suneja
Mar 4, 2018·Journal of Cancer Research and Clinical Oncology·Ernest BarthélemyRaj K Shrivastava
Aug 8, 2018·Future Oncology·Robin A BuerkiRimas V Lukas
Feb 28, 2018·Orbit·Dane H SlentzTamer N Mansour
May 11, 2017·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Majed AlghamdiGerald Lim
Jul 20, 2019·Expert Opinion on Pharmacotherapy·Syed Ali AhsanMichael E Sughrue
Jul 26, 2016·Journal of Korean Neurosurgical Society·Jeong-Kwon KimEun Jung Lee
Apr 22, 2020·British Journal of Neurosurgery·Francesco MaiuriOreste de Divitiis
Dec 7, 2017·Oncotarget·Hiroyuki TakedaChifumi Kitanaka
May 12, 2020·Brain Tumor Research and Treatment·Sung Kwon KimUNKNOWN KSNO Guideline Working Group
May 8, 2020·Bioscience Reports·Xiaodong ChenYugong Feng
Jul 10, 2019·British Journal of Neurosurgery·Lindsey S BulleidPaul A Leach
Mar 21, 2020·Journal of Neuro-oncology·Hriday P BhambhvaniMelanie Hayden Gephart
Jul 12, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P D Delgado-López, E M Corrales-García
Feb 26, 2020·Case Reports in Neurological Medicine·Maria das Dores Medina-Lopes, Luiz Augusto Casulari
Jun 13, 2020·Neuro-oncology Practice·Erik ThurinAsgeir Store Jakola
Nov 20, 2016·Journal of Neuro-oncology·Suresh K BalasubramanianSamuel T Chao
May 18, 2018·F1000Research·Nawal ShaikhJeffrey Raizer
Sep 29, 2020·Frontiers in Neurology·Tomas Garzon-MuvdiEdward Pan
Nov 3, 2020·Current Neurology and Neuroscience Reports·Pedro David Delgado-LópezJavier Martín-Alonso
Nov 17, 2020·Frontiers in Oncology·Kristin HuntoonSonika Dahiya
Nov 11, 2017·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Whitney A SumnerArthur K Liu
Feb 9, 2021·Neuro-oncology·Masahiro YamamotoChifumi Kitanaka

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Clinical Trials Mentioned

NCT00895622

Software Mentioned

DigitizeIt
Google Scholar
PubMed

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.